钱富人
2022-12-11

6

國家藥監局已批准40個新冠病毒抗原檢測試劑

@经济观察报：
據國家藥監局網站消息，12月11日，經國家藥監局審查，批准中山生物工程有限公司的新冠病毒抗原檢測試劑產品。截至目前，國家藥監局已批准40個新冠病毒抗原檢測試劑產品。 藥品監督管理部門將加強相關產品上市後監管，保護患者用械安全。 附：國家藥監局已批准新冠病毒抗原檢測試劑
國家藥監局已批准40個新冠病毒抗原檢測試劑

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet